Considerations in drug handling in renal disease.

作者信息

Sica Domenic A

机构信息

Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Virginia Commonwealth University Health System, Richmond, Virginia 23298-0160, USA.

出版信息

Clin Pharmacokinet. 2007;46(8):677-9. doi: 10.2165/00003088-200746080-00004.

DOI:10.2165/00003088-200746080-00004

PMID:17655374

Abstract

摘要

相似文献

Considerations in drug handling in renal disease.

Clin Pharmacokinet. 2007;46(8):677-9. doi: 10.2165/00003088-200746080-00004.

Case discussion: impaired renal function and tolerance to high altitude.病例讨论：肾功能受损与对高海拔的耐受性

High Alt Med Biol. 2002 Fall;3(3):293-5. doi: 10.1089/152702902320604287.

Hypertension in infantile polycystic renal disease. The importance of early recognition and treatment of severe hypertension in polycystic renal disease.

Clin Pediatr (Phila). 1972 Apr;11(4):232-5. doi: 10.1177/000992287201100410.

Hypertension and renal disease.高血压与肾脏疾病。

Practitioner. 1993 Feb;237(1523):173-5.

Management of hypertension in a geriatric cat.老年猫高血压的管理

Can Vet J. 2004 May;45(5):427-9.

Treatment of hypertension.

Semin Nephrol. 1996 Nov;16(6):555-66.

[A nephrologist's viewpoint of renal denervation].

Zhonghua Nei Ke Za Zhi. 2013 Jan;52(1):8-10.

[Therapy for hypertension associated with kidney disease].

Nihon Naika Gakkai Zasshi. 2003 Feb 10;92(2):264-9.

Prescribing in pregnancy. Hypertension and renal disease.

Clin Obstet Gynaecol. 1981 Aug;8(2):439-53.

Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.肾实质性疾病伴蛋白尿的高血压患者的降压治疗与肾小球大小选择性

Clin Nephrol. 2002 Oct;58(4):321-4.

引用本文的文献

Pharmacokinetics and dosage adjustment in patients with renal dysfunction.肾功能不全患者的药代动力学与剂量调整

Eur J Clin Pharmacol. 2009 Aug;65(8):757-73. doi: 10.1007/s00228-009-0678-8. Epub 2009 Jun 20.

本文引用的文献

Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment.口服直接肾素抑制剂阿利吉仑单独及与厄贝沙坦联合应用于肾功能损害患者时的药代动力学

Clin Pharmacokinet. 2007;46(8):661-75. doi: 10.2165/00003088-200746080-00003.

Hypertension, renal disease, and drug considerations.高血压、肾脏疾病及药物注意事项。

J Clin Hypertens (Greenwich). 2004 Oct;6(10 Suppl 2):24-30. doi: 10.1111/j.1524-6175.2004.03940.x.

Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.全身性高血压中的β-肾上腺素能阻滞剂：与现行指南相关的药代动力学考量

Clin Pharmacokinet. 2002;41(7):505-16. doi: 10.2165/00003088-200241070-00004.

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.《肾脏病生存质量指导（K/DOQI）慢性肾脏病临床实践指南：评估、分类及分层》

Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266.

Prediction equations to estimate glomerular filtration rate: an update.估算肾小球滤过率的预测方程：最新进展。

Curr Opin Nephrol Hypertens. 2001 Nov;10(6):785-92. doi: 10.1097/00041552-200111000-00009.

Diuretic therapy.利尿疗法

N Engl J Med. 1998 Aug 6;339(6):387-95. doi: 10.1056/NEJM199808063390607.

Kinetics of angiotensin-converting enzyme inhibitors in renal failure.

J Cardiovasc Pharmacol. 1992;20 Suppl 10:S13-20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验